News | News By Subject | News by Disease News By Date | Search News

Disease News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Facing Public Backlash and Pressure from Clinton, Mylan (MYL) Caves and Lowers Price of EpiPen     8/25/2016
Amgen (AMGN) Remains Hush-Hush Over FDA Rejection of Parsabiv     8/25/2016
Teva (TEVA) Stock Plummets After Two Patents are Invalidated by Mylan (MYL)     8/25/2016
Novartis AG (NVS) Touts Phase III Data for MS Drug Siponimod     8/25/2016
Clovis Oncology (CLVS) Rockets as FDA Agrees to Priority Review of Rucaparib NDA     8/24/2016
Celgene (CELG)'s Once-Nightmare Drug Turned Blockbuster Returns     8/23/2016
Outrage Ensues After Mylan (MYL) Raises EpiPen Price by 400%     8/23/2016
Why Eli Lilly (LLY) Execs are Bullish About Its Alzheimer's Drug Solanezumab     8/23/2016
Amgen (AMGN) Responds to 'Flawed' Cholesterol Study     8/23/2016
Struggling Tokai Pharma (TKAI) Nixes Enrollment in Mid-Stage Prostate Cancer Study     8/23/2016
Eli Lilly (LLY)'s Incoming CEO May Carry First Alzheimer's Drug Across The Finish Line     8/22/2016
Sanofi (SNY) Loses Lead on New Diabetes Drug After FDA Delay     8/22/2016
Sarepta (SRPT)’s Duchene Muscular Dystrophy Drug: Evaluating the Placebo Effect     8/19/2016
Bay Area's Portola (PTLA) Plummets as FDA Rejects AndexXa NDA     8/19/2016
19 Deaths Force Medtronic (MDT) to Warn Doctors on Heart Valve Delivery System     8/18/2016

News from Around the Web
How Fish Oil Pills Can Reverse The Effects Of A Fatty Diet, University of Sao Paulo Study     8/25/2016
The Science Of Why Bugs Are Attracted To Certain People     8/25/2016
Low-Cost Diabetes Detection Devices Stuck In Pipeline; As Medical Body And Companies Play Blame Game     8/25/2016
Autonomous University Of The State Of Morelos Scientists Creating A Special 3-D Printed Valve To Treat Microcephaly In Unborn Babies     8/25/2016
University of Otago Research Goes To Rugby Team's Heads     8/25/2016
Gene Tests Identify Breast Cancer Patients Who Can Skip Chemotherapy, UCSF Study Says     8/25/2016
Pot-Smoking Rats Are Lazy, University of British Columbia Study Shows     8/24/2016
Should You Be Drinking A2 Milk?     8/24/2016
Drinking Green Tea Could Prevent Deadly Artery Explosion, Kyoto University Study     8/24/2016
Brain Scans Of Brazilian Babies Show Array Of Zika Effects, Harvard Medical School Study     8/24/2016
Pfizer (PFE)'s $14 Billion Buy Signals That Cancer Drug Prices Will Remain High     8/23/2016
DNA Brain Injection Could Help Control Parkinson's Symptoms, Voyager Therapeutics (VYGR) Reveals     8/23/2016
Could Mouthwash Fight Gonorrhea? Monash University Study     8/23/2016
"Bagpipe Lung" Warning For Wind Musicians, Wythenshawe Hospital Study     8/23/2016
How Women Can Deal With Periods In Space, King's College London Reveals     8/23/2016

Press Releases
Pivotal Study Results Published In The New England Journal of Medicine Confirm Safety And Efficacy Of InSightec's Exablate Neuro System For The Treatment Of Essential Tremor     8/25/2016
Sunesis (SNSS) Announces Publication in "Drugs" Detailing Molecular And Pharmacologic Properties Of Vosaroxin     8/25/2016
NeuroDerm (NDRM) Initiates Patient Enrollment In A Phase III Trial Of ND0612L For The Treatment Of Parkinson’s Disease     8/25/2016
SCYNEXIS, Inc. (SCYX) Receives Orphan Drug Designation For SCY-078 For The Treatment Of Invasive Aspergillus Infections     8/25/2016
Themis: Phase 2 Trial Of Leading Chikungunya Vaccine Candidate Started     8/25/2016
Pear Therapeutics Release: The Largest And Longest Study Of Patients With Schizophrenia Interacting With Digital Therapeutics Results Released     8/25/2016
TaiGen Biotechnology Out-Licenses Taigexyn (Nemonoxacin) To Productos Científicos For The Latin American Market     8/25/2016
Armetheon Announces Positive Results Of Pharmacokinetics Study Of Tecarfarin Versus Warfarin     8/25/2016
INSYS Reports Phase III Trial Of Sublingual Buprenorphine Spray Met Primary Endpoint In Patients With Moderate-To-Severe Postoperative Pain After Bunionectomy     8/24/2016
Nymox Pharmaceutical (NYMX) Reports Successful New Long-Term Fexapotide Placebo Crossover Study Results: Major Reduction In Incidence Of Surgery     8/24/2016
Vybion, Inc. Release: Novel Gene Therapy Drug For Huntington's Disease     8/24/2016
RegeneRx Biopharmaceuticals, Inc. (RGRX) Joint Venture To Begin Second Phase 3 Study Of RGN-259 For Dry Eye Syndrome In 3rd Quarter     8/24/2016
Inotek (ITEK) Announces The Completion Of The Recruitment Phase Of MATrX-1, The First Phase 3 Clinical Trial Of Trabodenoson For Glaucoma     8/24/2016
BioPharmX Enrolls First Subject In Opal Phase 2b Clinical Trial Of Bpx-01 Topical Minocycline For The Treatment Of Acne     8/24/2016
Vaccinex, Inc. Receives Orphan Drug Designation From U.S. FDA For Its Lead Antibody Product Candidate, VX15, As A Potential Treatment For Huntington’s Disease     8/24/2016